CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Nasopharyngeal (NP) swabWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug1090 Hydroxychloroquine + azithromycin Wiki 0.71
drug1086 Hydroxychloroquine Wiki 0.10

Correlated MeSH Terms (5)

Name (Synonyms) Correlation
D011024 Pneumonia, Viral NIH 0.13
D011014 Pneumonia NIH 0.06
D007239 Infection NIH 0.06
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.06

There is one clinical trial.

Clinical Trials

1 A Research Platform to Screen Patients in Oncology and Assess Impact - RESPONSE

The purpose of this study is to investigate the impact of COVID -19 in the cancer patient population. This will be done by looking at the rate of asymptomatic COVID-19 infection in cancer patients receiving cancer therapy, as well as their immune response and outcome. This is a sub-study of the U-DEPLOY study: UHN Umbrella Trial Defining Coordinated Approach to Pandemic Trials of COVID-19 and Data Harmonization to Accelerate Discovery. U-DEPLOY helps to facilitate timely conduct of studies across the University Health Network (UHN) and other centers.

NCT04373005 Covid-19 Cancer Diagnostic Test: Nasopharyngeal (NP) swab

Primary Outcomes

Measure: Rate of asymptomatic COVID-19 infection among cancer patients receiving cancer therapy

Time: 7 months

Secondary Outcomes

Measure: Rate of sero-conversion in cancer patients

Time: 7 months

No related HPO nodes (Using clinical trials)